Irina Klimanskaya

Irina Klimanskaya

Company: Astellas Institute for Regenerative Medicine

Job title: Senior Director, Translational Science & Development


Scaling Up Differentiation Process Efficiently: Key Parameters Defined by Cell Biology, Technology, & Regulatory Requirements 3:30 pm

Understanding the type of differentiated derivatives of PSC defines the manufacturing process (including PSC expansion, differentiation, expansion of derivatives) to overcome unique challenges Scaling up and compliance with regulatory requirements often requires additional optimization of the process due to impact of raw materials and GMP compliant procedures on cell health and properties Appreciating upgraded process…Read more

day: Conference Day Two

Roundtable Discussion: To Auto or to Allo? Evaluating the Future of iPSC-Derived Cell Therapies to Inform Our Next Steps 10:00 am

Considering the practicalities of a scaled-up autonomous approach to re-evaluate its clinical acceptance Understanding the transection between autologous and allogeneic translational approaches to promote a holistic iPSC strategy Identifying how industry, service providers and academia can collaborate to support the advancement of iPSCs to the clinicRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.